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(NZB ×  NZW)F1, MRL, and BXSB mice, and to a lesser extent NZB mice, develop 
a  progressive autoimmune  disease  that  simulates  the  human  disease  systemic lupus 
erythematosus (SLE). 1 The murine syndrome is marked by B-lymphocyte hyperactiv- 
ity manifested  by hypergammaglobulinemia,  spontaneous  polyclonal antibody pro- 
duction, and secretion of various autoantibodies  (1-4). 
The  mechanisms  responsible  for  the  B-cell  hyperactivity  in  these  mice  remain 
unexplained. The cause may be one defect or combinations of defects such as primary 
genetic or acquired  B-cell malfunction,  the presence of endogenous or exogenous B- 
cell  activators,  the  lack of a  negative  influence  by suppressor  T  cells,  an enhanced 
positive influence by helper T  cells, defects in subsets of intra-T regulatory cells  (i.e., 
Ly 123+), and defects in other elements of the immune system such as macrophages. 
Evidence for functional or numerical  inadequacies  in antigen-nonspecific suppressor 
T  ceils  (5),  lack of regulatory  Ly  123 + T  cells  (6,  7),  and  lack of acceptor sites  for 
suppressor messages on the surfaces of B cells (8)  has been reported in one or another 
of the susceptible strains. 
Because Ig secretion  represents  an  indicator  of the  B-cell  maturational  stage  and 
activity, we have investigated  in vitro the magnitude,  nature,  and regulation of the 
spontaneous and mitogen-induced secretion of Ig by splenic lymphocytes from these 
autoimmune  mice.  Our  results  indicate  that  all  of the  above  autoimmune  murine 
strains  do in fact have an increased frequency of mature,  Ig-secreting B cells  (IgSC) 
in their spleens at one time or another as compared to age-matched, immunologically 
normal strains.  The enhanced B-cell maturity, although apparent  in the early life of 
NZ mice (NZB, NZB ×  W), is somewhat delayed in MRL/I and BXSB mice in spite 
of an earlier  onset  of disease  in  the latter  two strains.  Antigen  nonspecific T-helper 
cell activity appears  to be heightened  only in older MRL/I  mice and T-nonspecific 
suppressor cell activity in all autoimmune strains is within normal limits. 
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Materials and Methods 
Mice.  All murine strains used in this study were bred and maintained in the Scripps Clinic 
and Research Foundation colony, La Jolla, Calif. The immunopathologic  characteristics of the 
autoimmune mice have been detailed elsewhere  (1, 9). For this report, it suffices to state that 
their 50% mortalities are: NZB of both sexes, 16-17 mo; NZB × W females, 8.5 mo and males, 
15  mo;  MRL/I  of both  sexes, 5±6  mo;  MRL/n,  17  and  23  mo  for  females  and  males, 
respectively; BXSB males, at 5-6 mo, BXSB females,  15 mo. The MRL/I and MRL/n mice 
are substrains of the MRL strain; the MRL/I has the lpr (lymphoproliferation) genes and the 
MRL/n lacks the lpr gene. The proliferating cells in older MRL/I mice are mostly of T-cell 
type (10). In these experiments, all mice tested were  females  except  for the BXSB strain for 
which, unless otherwise indicated, males were used. 
Mitogens.  Concanavalin A  (Con A)  was  purchased from Sigma Chemical Co.  (St.  Louis, 
Mo.).  Lipopolysaccharide (LPS)  from Escherichia coli K235 (phenol extract) was a generous gift 
from Dr. D. Morrison (Scripps Clinic and Research Toundation). 
Antisera.  An~i-mouse IgM, I¢ serum was prepared in goats immunized with mouse FII. The 
serum  obtained  was  affinity purified on  Sepharose-  (Pharmacia Fine Chemicals,  Div.  of 
Pharmacia, Inc., Piscataway, N. J.) bound APBC22 myeloma protein (IgM, to). This antiserum 
reacted with mouse IgG and IgM in double immunodiffusion.  A polyvalent anti-mouse Ig (IgG 
+  IgM +  IgA) was prepared by immunizing a rabbit with mouse Ig precipitated from serum 
with 50% ammonium sulfate. Rabbit anti-mouse IgG, rabbit anti-mouse IgM, and rabbit anti- 
mouse C3H  brain antibody specific  for  T  cells  were  all  purchased  from  Litton  Bionetics, 
Kensington, Md. Fluorescein isothiocyanate (FITC) F(ab')2 rabbit anti-mouse Ig (IgG +  IgM 
+  IgA) was obtained from N. L. Cappel Laboratories, Inc. (Cochranville, Pa.). 
Cell Preparation.  Cell suspensions were made aseptically by passing the murine spleen cells 
through a stainless steel screen in minimum essential medium (MEM; Grand Island Biological 
Co., Grand Island, N. Y.) supplemented with 2 mM glutamine, 10 mM Hepes buffer, pH 7.2, 
penicillin  and streptomycin, and 5% fetal bovine serum (FBS) (referred to hereafter as medium). 
The erythrocytes were lysed with 0.17 M NHCI (4°C, 10 rain); mononuclear  cells were washed 
twice in ice-cold medium and viable cells were counted by trypan blue dye exclusion. Peripheral 
blood mononuclear cells  (PBM)  were  enriched by passing peripheral blood through  Ficoll 
(Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.) -Hypaque (Winthrop Laboratories, New 
York) gradients. 
Preparation of Enriched B- and T-Cell  Populations.  B-cell enriched populations were obtained 
by treating whole murine spleen cell populations with mouse anti-Thy-l.2 serum plus comple- 
ment (C). In brief, portions of 1 ×  10  s spleen cells were first incubated (30 min, 4°C) with an 
appropriate amount of anti-Thy-l.2 serum (AKR anti-C3H), kindly provided by Dr. D. Katz 
(Scripps  Clinic and  Research  Foundation), prepared  as  described  (11). After  30  min, cell 
suspensions were washed once in medium without FBS and incubated for 45 min at 37°C in 
guinea pig serum (source of C) diluted 1:4 in medium without FBS. Cells were washed again 
twice with medium and subjected to Ficoll-Hypaque centrifugation. Live cells recovered from 
the  interface were  washed  and brought  to  2  ×  106  cells/ml medium. More  than  97%  of 
these cells bore surface Ig as evidenced by staining with FITC-F(ab')2 rabbit anti-mouse Ig. 
T  cell-enriched populations were  obtained by using the fluorescence-activated cell  sorter 
(FACS II; Becton, Dickinson & Co., Mountain View, Calif.) as follows: Spleen cells were first 
subjected  to  Ficoll-Hypaque centrifugation to  remove  dead  cells.  Thereafter,  cells  at  the 
interface were washed  and stained with an optimum amount of FITC-F(ab')2 rabbit anti- 
mouse Ig antibody, washed three times in medium containing  0.1% NaNa and brought to 2 X 
106 cells/ml medium before being subjected to cell sorting. FITC-stained cell suspensions were 
sorted  on  the  basis  of bright  fluorescence as  previously described  (12). Bright  cells  were 
contaminated with up to 1% of dull cells, and dull cells were contaminated with up to 0.2% of 
bright cells as judged by repeat analysis of sorted cells in the regular fluorescence microscope. 
The dull cells  (>95%  stained when incubated with FITC rabbit anti-mouse brain antibody) 
were considered to represent T cells. 
The Reverse Hemolytic Plaque Assay.  IgSC were detected by a reverse hemolytic plaque assay 
that has been described in detail (13). Briefly,  50 #l of a  10% suspension of sheep erythrocytes 
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a rabbi't anti-mouse IgM, •  antibody and 100/11 of a lymphocyte suspension in medium (1-2 
x  105 cells depending on the strain used)  were  pipetted into  10-  X  75-mm glass  test  tubes 
(Scientific  Products Div., American Hospital Supply Corp., McGraw Park, Ill.) containing  0.5 
ml  of a  0.5% solution of agarose  (Indubiose A.37,  L'Industrie Biologique  Francaise  SA, 
Gennevilliers, France) in medium. The contents were mixed and poured on microscope slides 
and allowed to gel. After incubation for  1 h at 37°C, the slides were floated in predetermined 
optimum dilutions of developing rabbit anti-mouse Ig, anti-mouse IgM, or anti-mouse IgG 
antiserum and incubated for  1 h at 37°C. The developing antiserum was replaced with 20% 
guinea pig serum (Pel Freeze,  Rogers,  Ark.)  as a source of C and then incubated for  1 final h 
at  37°C.  IgSC  were  then  detected  as  hemolytic plaques by using a  dissecting microscope 
(Bausch and Lomb, Rochester, N. Y.). 
To  determine the  in vitro roles  of T  cells  in spontaneous Ig secretion, we  assessed  the 
frequency of IgSC in 2 ×  105 cells of a whole spleen cell population compared to that of 2 ×  105 
cells in a population from which T cells had been depleted as described above. On the basis of 
the  results obtained and the  predetermined proportion of T  cells  in the  whole spleen cell 
population, the predicted frequencies of IgSC in the depleted population were determined. The 
percent reduction in IgSC by T-cell removal was determined by the formula: 
Net IgSC/106 T cell depleted population 
Percent reduction =  1 -  ×  100. 
Net IgSC predicted/106 T  cell depleted population 
The same  procedure,  adapted  from  Bell  et  al.  (15) and Roder et  al.  (16), was  used  for 
enumerating anti-single-strand DNA (ss-DNA)-secreting  cells, the only difference being that 
SRBC  were  coupled  with  ss-DNA  by  the  chromic  chloride  method.  Calf thymus  DNA 
(Worthington Biochemical Corp., Freehold, N. J.) was rendered single stranded by heating to 
100°C for 12 min, followed by rapid cooling in an ice bath. The binding  of DNA to erythrocytes 
was assessed by a  microhemagglutination assay using a  human SLE serum with anti-DNA 
activity. The net numbers of anti-DNA plaques were determined by subtracting the plaques 
obtained with uncoupled SRBC. The net PFC obtained were inhibited in a dose-dependent 
manner if free ss-DNA was added in the agarose. 
Culturing of Cells for the Generation of IgSC.  Apart from determining the frequency of IgSC 
present  in  freshly  obtained cell  populations  (spontaneous IgSC),  we  also  determined  the 
frequency of IgSC after culturing in vitro with and without bacterial LPS. Unseparated spleen 
cells, as well as T and B cells, and combinations thereof (Results), were suspended at a density 
of  1  ×  106  cells/ml  in  RPMI-1640  medium  (Microbiological Associates,  Bethesda,  Md.) 
supplemented with  5%  FBS  (from  a  lot  predetermined  to  have  low  mitogenic activity), 
penicillin, streptomycin and fungizone, and 2 mM L-glutamine. Portions of 200/~1 (1-2 ×  10  ~ 
cells)  were  cultured 3  d  at  37°C  in  5%  CO2  in  the  presence or  absence of LPS.  At  the 
termination of culture, the cells were washed twice in medium and assayed for the number of 
IgSC. 
Suppression of Spontaneous and Mitogen-induced IgSC.  To study the effect and state of suppressor 
T  cells and their products on the spontaneous IgSC, spleen cells were cultured for 48 h either 
in RPMI-1640 medium alone or in medium to which various amounts (0.5-20 #g/well) of 
concanavalin A (Con A) had been added. To study the effect of suppressor T cells on the LPS- 
induced IgSC, we used direct and indirect assays as described (3). For the direct assay, spleen 
cells were cultured for 3 d with 20 ~g/well of LPS and with Con A in amounts ranging from 
0.5 to  I0/~g/well or without Con A and washed twice, after which the frequency of IgSC was 
determined. In the indirect assay, spleen cells (2 ×  105) were incubated with various amounts 
(2-20/×g/well) of Con A for 48 h along with untreated controls in RPMI-1640 supplemented 
as above. These Con A-preactivated cells were then washed twice and added to fresh cultures 
containing 2 ×  l0  s cells of the indicated splenocytes together with 20 ~tg/well  of LPS. IgSC 
were  enumerated at  day 3.  Controls with LPS-stimulated cells that  did not receive  Con A- 
preactivated cells were also included. 
Detection of Cells Staining for Intracytoplasmic Ig.  Aliquots of erythrocyte-depleted spleen cells 
were analyzed for cytoplasmic Ig after fixation in a  5% acetic acid, 95% ethanol solution at 
-20°C followed  by washing and staining with FITC-F(ab')2 anti-moUse Ig and subsequent 
processing in the FACS II. THEOFILOPOULOS,  SHAWLER,  EISENBERG,  DIXON  449 
Results 
Spontaneous IgSC in Spleens of Autoimmune and Normal Mice.  For assessing the state of 
spontaneous  Ig  secretion,  spleen  cells  were  plaqued  immediately  after  they  were 
obtained. The results of this experiment are depicted in Fig.  1 and indicate that at the 
stage of clinically obvious disease, four of the five autoimmune strains  (NZB, NZB 
×  W, MRL/I and BXSB) had four- to sixfold higher frequencies of IgSC (0.4-0.6% 
of the whole spleen cell population)  than  the  three immunologically normal  H-2- 
matched  strains  (BALB/c,  C3H/St,  C57BL/6).  The  MRL/n  autoimmune  strain, 
which develops the disease in the second year of life, although showing some tendency 
to increase in frequency of IgSC with age, was within the normal limits at the latest 
time tested (7 mo of age). Similarly, BXSB females, which develop delayed autoim- 
mune disease, were within the normal limits at the latest time tested (6 mo of age). In 
the NZB and NZB ×  W  mice, the high frequency of splenic IgSC was detectable as 
early as  1 mo of age and increased somewhat thereafter. In contrast, in BXSB male 
and MRL/I female mice the high frequency of IgSC was first observed at or a  little 
before the clinical onset of the disease (3 mo of age). 
The number of IgSC  in  freshly prepared peripheral blood was  also  determined. 
Although the frequency of IgSC in peripheral blood was lower than that in syngeneic 
spleens,  the trends were similar,  i.e., autoimmune  mice had  severalfold higher fre- 
quency of IgSC than normal strains (Table I). 
IgSC Represent Active Ig  Secretion.  Because  the  presence  of thymocytotoxic and 
cytophilic antibodies on cell surfaces may lead to false-positive plaques, we performed 
two types of experiments to demonstrate that the spontaneous plaques reflected active 
Ig secretion by lymphoid cells rather than release of Ig passively bound to cells. First, 
spleen cells taken from five NZB mice at 6 mo of age were preincubated for 2 h  at 
37°C  in  medium  containing 5%  FBS  to allow  for release of cytophilic antibodies. 
After the ceils were washed  three times,  the number of IgSC was  determined and 
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TABLE I 
Circulating IgSC in Autoimmune and Normal Murine Strains 
Strain  Age  IgSC/10  n PBM cells 
mo 
NZB  1  511 + 213" 
8  780 + 254 
NZB × W  1  406 + 61 
9  660 -+ 205 
MRL/I  1  50 ±  13 
5  395 +  102 
MRL/n  1  29 ±  12 
8  73 +  18 
BXSB  1  61 __ 16 
6  161 ±  102 
C3H/St  2  20 +  7 
7  49+9 
BALB/c  2  55 ±  12 
8  69+  12 
* Numbers represent the mean _  SD of five individual mice. 
compared  with  the  number  of  IgSC  found  when  the  same  cells  were  assayed 
immediately after isolation. There was no significant fall in the number of IgSC (<3.4 
+  1.1%)  as a  result of incubation as would be expected if passive carry-over of Ig was 
a  factor in the assay. However, spontaneous  formation of IgSC was reduced signifi- 
cantly upon further incubation in vitro. A  representative time course for spontaneous 
IgSC in NZB and BALB/c spleen cells cultured in vitro is shown  in Fig. 2.  After 24 
h  of culture, there was a  60%  reduction and at 48 h  there was a  76.5%  reduction in 
the number of IgSC compared to the starting value in NZB spleen cells. 
Second,  the  action  of cycloheximide,  an  inhibitor  of  protein  synthesis,  on  the 
number of IgSC was also examined. Some of the pooled spleen cells from three NZB 
mice were assayed immediately after they were obtained, and others were incubated 
with medium or with medium containing cycloheximide (100 ~g/ml) for 2 h  at 37°C 
and then assayed for the number of IgSC. Spleen cells incubated for 2 h  at 37°C  in 
medium alone had almost the same frequency of IgSC as cells that were not incubated 
(4, 328 versus 4,180 IgSC/106 cells). However, incubation for 2 h  with cycloheximide 
decreased the number of IgSC to  112/106 spleen cells. Cell viabilities, as determined 
by trypan blue exclusion, were identical in treated and untreated populations. 
The number ofspontaneeus IgSC detected by the hemolytic plaque assay correlated 
with  the  number  of Ig-synthesizing cells found  by staining for  intracytoplasmic Ig 
with FITC-anti-mouse Ig (Table II). Older NZB, NZB X W, and MRL/I  strains had 
higher  frequencies  and  numbers  of  intracytoplasmic  Ig-containing  cells  than  the 
normal strains; ~6-7% of the total spleen cells in the former vs.  1.3% in the latter. In 
older BXSB  mice, the  frequency  of Ig-containing cells was  only two  to three times 
higher than that of older normal mice. With advanced clinical disease, NZ mice had 
5-  to  10-fold and  MRL/1  mice had  a  30-fold  higher number  of Ig-containing cells 
than younger, syngeneic animals. 
Isotypes of lg Secreted Spontaneously by Splenic Lymphocytes.  By developing the plaques 
with antisera specific for the two major murine isotypes, IgG and IgM, we found that 
all autoimmune  and  normal strains tested during youth spontaneously formed con- 20 
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TABLE II 
Cytoplasmic Ig-containing  Cells in Spleens of Autoimmune and Normal Murine Strains 
Strain  Age  Percentage of cyto-  No. spleen cells  No. of cytoplasmic 
plasmic Ig  + cells  Ig  + cells 
mo  %  ×  lO -6  ×  10 -6 
NZB  1  2.20 ±  0.65*  52.8 ±  23.2  1.16 ±  0.15 
9  6.67 -  2.40  79.5 ±  30.8  5.30 ±  0.74 
NZB x  W  1  1.94 --. 0.83  49.6 __. 23.3  0.96 +  0.19 
9  6.83 :k 2.31  141.6 ±  19.5  9,67 ±  0.45 
MRL/I  1  1.16 ±  0.26  102.8 ±  25.7  1.19 ±  0.06 
4.5  6.06 ±  2.02  546.7 ±  136.3  33.13 ±  2.7 
BXSB  1  1.08 ::b 0.40  74.8 ::!: 12.8  0,80 ±  0.05 
5  2.12 ::k 0.80  153.5 ±  12.0  3,25 +  0.09 
BALB/c  1  1.21  ±  0.50  79.2 +  11.1  0.95 +  0.02 
8  1.23:1:0.45  62.4 ±  18.2  0.76 +_ 0.08 
C57BL/6  1  1.24 ±  0.37  41.6 ±  16.2  0.51  ±  0.06 
12  1.13 ±  0.11  57.1  ±  14.4  0.64 ±  0.01 
* Numbers represent the mean ~  SD of five individual mice. 452  Ig SECRETION  IN SYSTEMIC LUPUS  ERYTHEMATOSUS  MICE 
TABLE III 
Isotypes of lg Secreted Spontaneously by Spleen Cells of Autoimmune and Normal Murine 
Strains 
Strain  Age 
IgSC/106 Cells 
Total Ig  IgG  IgM 
mo 
NZB  1  2,319 _ 822*  424 ± 203  1,495 + 719 
7  4,351 +  1,230  2,I93 + 338  1,718 -4- 660 
NZB × W  1  2,754 ±  1,019  518 _  174  1,509 + 619 
7  4,660 + 507  2,686 ± 902  1,855 + 383 
MRL/I  1  529 +  180  181 ± 54  377 ±  104 
4  3,481 ±  1,117  1,992 ± 427  1,282 ± 724 
BXSB  1  933 ±  178  253 ± 99  491 :t: 186 
5  2,353 ± 685  1,172 ± 329  820 ± 283 
BALB/c  1  785 ±  109  117 ± 25  603 ±  113 
7  1,410 ± 319  354 ± 83  1,068 ± 297 
CSH/St  1  1,128 ± 328  266 ± 38  858 ±  152 
11  1,404 ±  160  392 +  107  884 ± 87 
C57BL/6  1  894 ± 79  168 ±  111  503 ± 66 
10  1,203 + 310  274 ±  153  708 + 204 
* Numbers represent the mean -  SD of five individual mice. 
siderably higher frequencies of IgM-secreting cells than IgG-secreting cells (Table III). 
However, in contrast to immunologically  normal strains, which show almost the same 
magnitude and isotype profile of Ig secretion in youth and advanced age, the older 
autoimmune mice not only had higher frequencies of total IgSC as well as IgG- and 
IgM-secreting cells than the younger mice, but also they switched from predominantly 
the IgM isotype at youth to predominantly  the IgG isotype. The increase in frequencies 
of  IgGSC  in  older  as  compared  to  young autoimmune mice  was  approximately 
fivefold for the NZ and BXSB mice and 11-fold for the MRL/1 strain. The sum of the 
IgG- and  IgM-secreting cells  in  all  mice  tested  approached  the  total  number of 
spontaneous IgSC. 
Frequency of Spontaneous Autoantibody Secreting Cells.  Because one of the major autoim- 
mune  responses  in  all  SLE  mice  is  that  directed  against  DNA,  we  assessed  the 
proportion of anti-ss-DNA-secreting  cells of the total spontaneous IgSC cells of young 
and old mice (Table IV). Young mice, both autoimmune and normal, had very low 
frequencies of anti-ss-DNA-secreting  cells in their spleens. As expected, spleens of the 
older  autoimmune mice  contained a  significantly higher  number of anti-ssDNA- 
secreting cells than spleens of the normal mice; these numbers were highest in older 
NZB ×  W  and MRL/I mice followed by NZB and BXSB mice. In older MRL/1 and 
NZ  mice,  -1  of 5-10 of spontaneous IgSC  secreted  anti-ss-DNA antibodies (0.05- 
0.09% of the total spleen cell population). In BXSB mice, 1 of 29 IgSC secreted anti- 
ss-DNA antibodies (0.009% of the total spleen population). 
Effect  of T cells on the Frequency of Spontaneous IgSC.  The influence of T  cells on the 
spontaneous synthesis and secretion of Ig by murine spleen cells was then investigated 
in vitro. As shown in Table V, removal of T  cells resulted in a  significant reduction 
of the  frequency of IgSC in both autoimmune and normal spleen cell populations. 
The reduction was greater in T-depleted spleen cells of older MRL/1 mice than in the THEOFILOPOULOS,  SHAWLER,  EISENBERG,  DIXON 
TABLE  IV 
Frequencies of Spontaneous Anti-ss-DNA-secreting Cells in Spleens of 
Autoimmune and Normal Murine Strains 
453 
Strain  Age  IgSC/10  6 cells  Anti-ss-DNA-secreting 
cells/10  6 cells 
rllo 
NZB  1  3,560 ±  902*  48 ±  18 
7  4,300 ±  819  507 ±  102 
NZB x  W  1  3,804 ±  705  63 ±  9 
7  4,815 ±  1,004  906 ±  249 
MRL/I  1  1,017 ±  417  24 ±  11 
4  3,692 ±  518  539 ±  83 
BXSB  1  1,150 ±  203  17 ±  5 
5  2,784 ±  296  96 ±  13 
BALB/c  1  1,094 ±  103  12 ±  6 
8  1,226 ±  382  19 ±  6 
C57BL/6  t  1,150 ±  117  10 ±  4 
8  1,413 ±  94  23 ±  7 
* Numbers represent the mean ±  SD of three individual mice. 
TABLE  V 
Effect of T Cells on the Spontaneous In Vitro Ig Secretion of Spleen Cells  from A utoimmune and Normal 
Murine Strains 
Percentage  IgSC/10  6 cells  Predicted No.  Percentage 
IgSC/10  6 T-cell 
Strain  Age  Thy-l.2 + cells  Unseparated  T-cell depleted  depleted  reduction 
mo  %  % 
NZB  1  44  1,750 ±  418"  1,620 ±  84  3,125  48.2 
6  25  3,655 ±  519  1,947 +  193  4,873  60.0 
NZB × W  1  41  2,475 +  306  1,980 +  292  4,194  52.8 
6  26  3,930 ±  732  1,819 ±  96  5,310  65.7 
MRL/1  1  40  1,100 +  123  723 ±  79  1,833  60.5 
4  78  2,885 ±  404  2,150 ±  266  13,113  83.6 
BXSB  l  52  934 ±  183  949 ±  56  1,945  51.3 
5  39  2,500 ±  477  1,800 +  313  4,098  56.0 
C57BL/6  1  38  756 ±  132  616 ±  103  1,219  49.4 
8  37  875 ±  2l 1  687 ±  88  1,388  50.5 
*'Numbers represent the mean ±  SD of three experiments. Pools of three spleens for each age point were 
used in each experiment. 
young ones. It should be emphasized  that  the lymphocytes  used in these experiments 
were not triggered with mitogens and were cultured  only long enough  to complete the 
assay  (3 h). 
Effect of Polyclonal B-CeU Stimulators (LPS) on IgSC.  The  ability of LPS  to induce or 
maintain  splenic B-cell differentiation and  Ig secretion, as well as the optimum  dose 
for this mitogen, were examined  after preliminary  studies indicated  that the response 
in  both  normal  and  autoimmune  mice  was  highest  on  the  third  day  of culture.  As 
depicted  in  Fig.  3,  spleen  cells from  1-mo-old  NZB  X  W  and  NZB  mice stimulated 
with LPS  (0.02 #g/well)  had a  5- to  10-fold higher frequency of IgSC cells than spleen 
cells  from  the  two  other  autoimmune  strains  (MRL/I,  BXSB)  or  several  normal 
strains. However, even cells from NZ  mice incubated  for 3  d  with optimal  amounts  of 454  Ig  SECRETION  IN  SYSTEMIC  LUPUS  ERYTHEMATOSUS  MICE 
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LPS did not have a substantially higher frequency of IgSC than isogeneic spleen cells 
freshly  obtained  and  plaqued  immediately  (compare  with  Fig.  1).  It  should  be 
reiterated  that  the  spontaneous IgSC  decreased  substantially within  72  h  in  the 
absence of LPS. 
As shown in Fig. 4, the frequency of IgSC generated by LPS was greatly reduced 
in all older autoimmune mice as compared to young animals. The reduction in LPS 
responsiveness was acutely apparent with the onset of the disease. However, no similar 
reduction occurred in age-matched, immunologically  normal strains (C57BL/6, C3H/ 
St). 
As  shown  in  Fig.  5,  LPS-indueed Ig  secretion  by  spleen cells  from  normal and 
autoimmune mice  required  the  presence of syngeneic T  cells  in  the  culture.  The I  W 
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C57BL/6,  and BALB/c and 4  mo old  for  MRL/I and BXSB)  animals were added.  Each point 
represents the mean of three experiments. In each experiment, B cells and T  cells were obtained 
from a  pool of three spleens. 
response of T-depleted cells  (with  anti-Thy-l.2 +  C)  was  ~10-25%  that  of whole 
spleen populations  (Fig.  5A). Adding increments of T  cells to depleted populations 
restored the levels of IgSC almost to that obtained with whole spleen cell populations 
(Fig. 5 B). Control cultures of T  cells alone gave no (<25) plaques. 
Degree of T-Helper  Activity  in  Various Murine Spleen Cell Populations to LPS-induced  Ig 
Secretion.  Because Ig hypersecretion is more prominent  in older autoimmune mice 
than young ones, and because such hypersecretion may, at least in part, result from 
heightened T-helper activity, we examined the degree of help provided by increasing 
numbers of isolated T  cells from young and older animals to a standard number of 
LPS-stimulated  syngeneic  and  allogeneic  but  H-2-identical  B  cells  isolated  from 
spleens of young animals. The results of these experiments are summarized in Fig. 6. 
Increments ofT cells from young and older NZB and BXSB autoimmune mice added 
to a standard number of B cells from syngeneic young mice (1 mo old) provided--at 03 
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Fie.  7.  Suppression  of spontaneous IgSC by Con A. Pools of three spleens obtained from young 
(1 mo old) or older (3 mo old for MRL/I and BXSB, 6 mo old for NZB, NZB X W, MRL/n, and 
BALB/c) animals were used. Each point represents the mean of three experiments. 
all doses and at both ages--equal help in enhancing the frequency of IgSC after LPS 
stimulation.  Moreover,  the  help  provided  by T  cells  from  these  two  autoimmune 
strains to their own B ceils was not  significantly different  from that  provided by T 
cells  from young  and  older  normal  mice of the  same H-2  haplotype  (BALB/c  for 
NZB,  C57BL/6  for BXSB).  Similarly,  in  the  reverse situation,  when  T  ceils  from 
young and  old  NZB  and  BXSB  mice were  added  to  B  cells  from young,  normal 
counterparts,  the  help  was  not  significantly  greater  than  that  from T  cells  of the 
normal strains  (data not shown). The only notable exception was the MRL/I strain 
in  which  T  cell-enriched  populations  from older  animals  provided  twice  the  help 
offered by T  cells of young syngeneic animals or T  cells from young and older normal 
mice of the same H-2 haplotype (C3H/St). 
Effect  of Polyclonal T-Cell Stimulation  (Con A).  Spleen cell suspensions from young 
and old normal and autoimmune mice were cultured for 2 d with varying concentra- 
tions of Con A  (Fig.  7). The frequency of IgSC was significantly suppressed in vitro 
in  all autoimmune  and  normal  murine  strains  tested  when  5-10/tg  of Con  A  was 
included in the culture; however, these doses of Con A had no apparent effect on cell 
viability. Much lower concentrations of Con A  (0.05-1.0/Lg)  either had no effect on 
the frequency of IgSC, or in some experiments, actually enhanced the response in all 
strains examined. 
Effect  of Con A  on LPS-induced  Ig Secretion.  Con A-activated spleen cells have been 
found to suppress the polyclonal response induced by several B-cell mitogens, includ- 
ing LPS (17-19). However, it has been reported that Con A-treated spleen cells from 
older NZB and NZB ×  W  mice, in contrast to the cells from normal mice of similar 
age, lack the ability to suppress polyclonal B-cell mitogen-induced Ig secretion (5, 8). 
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Fie.  8.  Direct suppression of LPS-induced  IgSC by Con A. Cells  from the indicated  strain were 
cultured in the presence of a standard amount of LPS (20 #g/culture) and increasing concentrations 
of Con A. Each point represents the mean of four experiments. In each experiment a poor of three 
spleens was used. Young animals were 1 mo old and older animals were 3 mo old for MRL/I and 
BXSB and 6 mo old for NZB, NZB ×  W, MRL/n, and BALB/c. 
Therefore, we examined the direct effect of Con A on LPS-induced stimulation of Ig 
synthesis by culturing  spleen  cells with  a  standard  amount  of LPS and  increasing 
amounts of Con A.  As shown  in  Fig.  8,  high  doses of Con A  effectively suppressed 
LPS-induced Ig synthesis by splenic cells not only from young and older normal mice 
but also from young and older autoimmune mice, including the NZB and NZB X W 
strain.  It is important  to emphasize that  in  these experiments spleen cells from the 
older autoimmune mice were chosen only when adequately responsive to LPS. 
These results were reassessed by incubating spleen cells from young and older mice 
for 2  d  with  varying doses of Con  A  (0-20 #g/well),  washing  these  cells and  then 
adding them to fresh syngeneic cells derived from both young and older animals to 
which a standard amount of LPS was added. After 3 d, the cocultures were examined 
for the frequency of IgSC. As seen in Fig. 9A and B, spleen cells from both young and 
older  autoimmune  anima!s generated  Con  A-induced  suppressor cell  activity,  and 
LPS-responding B cells of young and old syngeneic animals were equally receptive to 
suppressor  messages.  That  LPS-stimulated  B  cells  of  autoimmune  mice  had  no 
apparent  defect  in  the  ability  to  receive  suppressor  signals  (directly  or  indirectly 
delivered  to  them)  was  also shown  when  Con  A-preactivated  BALB/c  spleen  cells 
suppressed spleen cells both from syngeneic young and older animals and from young 
and older NZB mice (Fig. 9 B, right panel). THEOFILOPOULOS,  SHAWLER,  EISENBERG,  DIXON 
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FtG.  9  (A and B).  Indirect suppression of LPS-induced  Ig synthesis by Con A. Spleen cells  from young 
(1  mo old)  or older (3 mo old for MRL/I and BXSB and 6 mo old for NZB, NZB  ×  W, C57BL/6,  and 
BALB/c) mice were cultured with increasing amounts of Con A for 48 h, washed and then added together 
with a standard amount of LPS (20 ,ttg/cuhure) to fresh syngeneic spleen cells  from young or older mice 
and cultured for 3 d.  Each point represents the mean of four experiments. In each experiment, a  pool of 
three spleens was used. 460  Ig SECRETION IN SYSTEMIC LUPUS ERYTHEMATOSUS MICE 
Discussion 
Our work had two principal aims. The first was to examine, by means of sponta- 
neous and mitogen-induced Ig secretion in vitro, the maturational stage of splenic B 
lymphocytes obtained during youth and advanced age from SLE-prone and immu- 
nologically  normal  murine  strains.  The  second  was  to  analyze  the  helper  and 
suppressor effect of their T  cells on the secretion of Ig by syngeneic and allogeneic but 
H-2 identical  B cells. Our results indicate that  all of the SLE-prone strains have in 
their spleens  at  one time or another greater frequencies and  numbers of mature B 
cells than the normal strains. Moreover, the B cell hyperactivity appears not to be the 
result  of a  defective T  suppressor cell  activity or of a  lack of acceptor sites  for T- 
suppressor messages on the B-cell surfaces. Several lines of evidence from other studies 
as well as these suggest that the B-cell hyperactivity in NZ mice may develop from an 
intrinsic  defect, whereas a  contributing  factor in MRL/1  mice may be enhanced  T- 
helper cell activity. 
The  advanced  maturity  of the  B  cells  from  NZ  mice,  evidenced  by  the  high 
frequency of IgSC in  their spleens,  was  detectable at  1 mo of age,  the earliest  age 
examined. This finding confirms the results of others who observed hypersecretion of 
Ig (2,  3)  and high frequencies of IgSC (20)  within the first days of life among these 
mice. Moreover, the high frequencies of IgSC in our study and those of Manny et al. 
(3)  and Tautog et al.  (20)  correlated well with the increased number of spleen cells 
containing intracytoplasmic Ig. Nevertheless, in NZ mice as well as the other autoim- 
mune and normal strains,  the absolute number of cells containing Ig far exceed the 
number of IgSC. 
The accelerated maturation of the B cells from NZ mice is further documented by 
(a) our observation  (10)  and the report of Cohen et al.  (21)  describing an increased 
ratio of surface IgM-:surface IgD-bearing cells and (b) our finding and the conclusions 
of others  (22)  that  LPS  responsiveness  of lymphocytes  is  reduced  with  aging  in 
autoimmune mice. The first finding suggests advanced B-cell maturity in the context 
of  studies  showing  a  decrease  of  surface  IgD  after  mitogenic  (23)  or  antigenic 
stimulation  (24),  whereas  the  latter  finding  may  be  explained  on  the  basis  of 
recruitment  and differentiation of virtually all potentially reactive B cells such that 
few  B  cells  are  available  to  generate  antibody  when  challenged  in  vitro  with  a 
polyclonal B cell activator. Collectively, these findings clearly demonstrate the excep- 
tionally early maturity and hyperactivity of B cells in NZ mice. 
The increased frequency of mature B cells, although apparent even at birth in NZ 
mice, is delayed for several months until just before the clinical onset of the disease in 
MRL/1  and  BXSB  mice, yet the two latter strains develop disease earlier than  NZ 
mice. The reason for this disparity between onset of B cell hyperactivity and onset of 
disease  is  not  clear,  but  the  immunopathologic  processes  may be more dependent 
upon the amount and/or quality (class, affinity) of specific autoantibodies produced 
than  the  time  when  nonspecific  B-cell  hyperactivity  appears.  In  fact,  isoelectric 
focusing studies (25) have shown that immediately before the disease begins, all SLE- 
prone strains exhibit new clonotypes of autoantibodies. 
The number of mature B cells increased with the progression of the disease in all 
autoimmune strains.  Of particular interest,  at the time when clinical  disease began, 
the IgSC in all these strains switched from a predominantly IgM to a predominantly 
IgG phenotype. This finding is in agreement with levels of these two isotypes in the THEOFILOPOLrLOS, SHAWLER, EISENBERG, DIXON  461 
sera of these mice (1),  with the isotypes of autoantibodies  deposited in their kidneys 
(1), and with the observation of others that anti-DNA antibodies in sera ofNZB ×  W 
mice  (26)  and  anti-DNA-containing  supernates  of cultured  lymphocytes  from  all 
autoimmune strains (27)  eventually switch from IgM to IgG later in the lives of these 
animals.  Moreover,  our  finding  correlates  with  our  previous  observation  that  the 
frequency  of surface  IgG  + cells  increases  with  age in  spleens  of autoimmune  mice 
(10).  Lymphocytes that bear IgG are known to differentiate to IgG-secreting cells and 
to exert negative influences on IgM secretion  (28,  29). 
A  relatively  large  proportion  (=15%)  of the  total  IgSC  in  all  older  SLE  mice 
spontaneously  secreted  antibodies  against  DNA,  one  of  the  major  autoantigens 
involved in their disease. A  similar frequency of spontaneous anti-ssDNA antibody- 
secreting cells has been described in NZB mice (15). Although in our study and others 
(15,  16), serum anti-DNA titers in the various strains correlated with the number of 
anti-DNA secreting cells, the foregoing analysis of auto-antibody production  at the 
cellular level offers the advantage that one can examine factors affecting production 
and  affinity of antibodies  without  interference by antigen.  What  proportion  of the 
total  IgSC is engaged  in producing antibodies  against  the plethora of autoantigens 
involved in this disease was not determined, but preliminary studies (data not shown) 
indicate that ~ 1-2% of the IgSC cells secreted autoantibodies against retroviral gp70, 
another  major  autoantigen.  Approximately  0.001%  of the  total  NZB  spleen  cells 
secrete antibodies against thymocytes in the presence of LPS (30). 
The spontaneous Ig secretion in vitro of both autoimmune and normal spleen cells 
was dependent  to some degree on the presence of T  cells, as others  (31)  found with 
human  peripheral  lymphocytes.  The  precise  mechanism  by  which  helper  T  cells 
induce precursor B cells to secrete Ig remains poorly understood. However, reduction 
of Ig secretion after T-cell removal would suggest that in vivo Ig production is more 
under the influence of helper than suppressor cells.  Reconstitution experiments with 
isolated T  and  B  cells are needed  to assure  that  Ig secretion  depends  on T  cells in 
vitro. 
Nonspecific activation of lymphocytes by mitogens has long been used as a  model 
for the study of antigen-induced  activation.  We  found  that  the  frequency of IgSC 
produced by normal and autoimmune mice after LPS stimulation was similar to the 
frequency of spontaneously produced IgSC, a finding similar to that of Manny et al. 
(3).  However, spleen  cells  from young NZ mice were  much  more sensitive to  LPS 
than the cells of other autoimmune and normal strains. It is possible that the enhanced 
B-cell maturity in NZ mice may result from the presence of low levels of endogenous 
polyclonal B cell activators. 
Polyclonal activation of B  cells to secrete Ig is generally thought  to depend only 
upon the direct interaction between LPS and its target B cell. However, we and others 
(32,  33) have convincing evidence to support the thesis that LPS-induced polyclonal 
B-cell activation in the mouse is regulated by T  cells. Thus, although Ig was secreted 
in  B  cell-enriched  populations,  this  phenomenon  was  markedly  enhanced  in  the 
presence of T  cells.  It is not  yet clear whether there is only one population of LPS- 
responsive B cells whose response is amplified by the action ofT cells or whether there 
are  two  populations  of B  cells,  one  activated  directly  by a  B  cell-LPS  interaction 
independent of T  cells, and another activated after LPS interacts with T  cells. 
Because LPS-induced Ig secretion was dependent on T  cells in our experiments, we 462  Ig SECRETION IN SYSTEMIC LUPUS ERYTHEMATOSUS MICE 
examined the amplifying effects of T  cells from young and older autoimmune and 
normal mice on syngeneic and H-2-identical allogeneic LPS-stimulated B cells from 
young animals. T cells from young and older NZ and BXSB mice provided essentially 
the same degree of help, and this help was equal to that by T  cells from H-2-matched 
normal strains. Thus, the heightened maturity of the B cells from these autoimmune 
mice  apparently  did  not  result  from  enhanced  T-helper  cell  activity.  The  very 
interesting finding, however, was  that  the splenic T  cells of the older MRL/I mice 
exerted excessive helper activity in vitro on isolated syngeneic B cells, compared to 
splenic T  cells  from young MRL/I  mice  and  cells  from  young and  older normal 
histocompatible mice.  As  we  have  demonstrated  (10),  the  ratio  of T  to  B  cells  is 
significantly greater in vivo than the maximal ratio employed in the present experi- 
ments in vitro. Therefore, one might well expect the helper activity observed in vitro 
to be greatly magnified in the intact animal. Splenic MRL/1 T  cells also heightened 
in  vitro production of anti-DNA  antibodies by syngeneic and  allogeneic cells  (34). 
Therefore, the lpr gene in MRL/1 mice may hasten autoimmune disease by causing 
proliferation of helper T  cells. However, such enhanced helper T-cell activity may not 
be  necessarily  a  prerequisite  for  the  development  of autoimmunity  because  the 
congenic  MRL/n  substrain  of mice  that  are  devoid  of the  lpr  gene  do  develop 
autoimmune disease, but much more slowly. 
The loss of suppressor T-cell function has been proposed (35,  36). Circumstantial 
and  experimental  data  both  support  and  refute the  concept  that  a  numerical  or 
functional defect in suppressor T  cells is responsible for the disease of NZ mice. Thus, 
NZB X W  hybrid spleen cells from older mice seem to be enhanced in the ability to 
mediate graft-versus-host reactions (37) and, after Con A stimulation, reduced in the 
ability to suppress  pokeweed mitogen  (PWM)-induced  Ig secretion or anti-hapten 
responses  (5).  Moreover,  an  inhibitory  Ly  123 +  T-cell  subset  may  be  absent  or 
inoperative in NZB  (6)  and MRL/1 mice  (38).  However, as our studies with NZB, 
NZB × W, BXSB, and MRL/I mice indicated, nonspecific Con A-induced suppression 
of Ig synthesis in vitro is within normal  levels very early in their lives and shortly 
before the clinical onset of overt disease. A possible explanation for the discrepancies 
in regard to antigen-nonspecific suppression in NZ mice may be that other investi- 
gators sometimes used cells from quite old animals, which we found in this study--as 
previously  reported  for  NZ  mice  (22)--have  far  less  capacity  for  polyclonal  B 
stimulation  than cells from young animals. This could result in an erroneous inter- 
pretation that suppression is lacking, whereas in actuality, polyclonal B-cell stimula- 
tion fails.  Another difference is that we used LPS as polyclonal stimulation, whereas 
they  used  PWM  (5).  Although  both  mitogens  induce  polyclonal  responses  in  the 
presence of T  cells, and their effect is suppressed by Con A, the cellular requirements 
and the responsible factors may be different. Moreover, those investigators examined 
the suppressive effects of Con A at just one concentration, 2 ~g, whereas we used Con 
A at doses ranging from 0.5 to 20/~g. Concentrations of 2/zg Con A/culture, in most 
instances  did  not  exert  significant  suppression  for  either  autoimmune  or  normal 
strains in our system. At any rate, in agreement with our findings, others have shown 
that  thymocyte-mediated  antigen-nonspecific  suppression  is  not  lost  with  age  in 
autoimmune hereditarily asplenic  (Dh/+)  NZB  mice  (39)  or in conventional NZB 
mice (3). Moreover, suppressor cells, as defined with Ly 23 alloantigen-expressing cells 
in  NZB  mice  (6)  or /-J-subregion-controlled alloantigen  in  MRL/1  mice  (10),  are THEOFILOPOULOS, SHAWLER, EISENBERG, DIXON  463 
normal  or  elevated  in  numbers.  Finally,  NZ,  MRL/I  and  BXSB  mice  are  quite 
normal as far as antigen-specific suppression (40-42) and, with the exception of one 
study  (43), young syngeneic thymocytes repeatedly transferred into NZB and  NZB 
×  W  mice had no inhibitory effect on autoantibody production or development of 
glomerulonephritis (44, 45). The combined results prompt us to question the assign- 
ment of a suppressor T-cell defect as the major pathogenic mechanism of autoimmune 
disease.  However, none of these arguments  exclude the  possible presence of subtle 
abnormalities  of suppressor  T  cells  undetectable  in  the  assays  employed  or  the 
development of late,  secondary suppressor  T  cell  or other  immunoregulatory cell 
abnormalities in  these animals.  The claim that  the defect in older NZB mice is an 
eventual lack of acceptor sites for suppressor messages on B cells (8) is not supported 
by our studies, because B cells from young and older NZB mice, as well as the other 
autoimmune strains, when stimulated with LPS to secrete Ig, were equally receptive 
to Con A-induced suppressor syngeneic and allogeneic T-cell messages. 
It is now clear that all SLE strains have hypergammaglobulinemia, many kinds of 
autoantibodies, and spontaneous polyclonal antibody synthesis by B cells early in life. 
While  still  very young,  NZB  mice  and  their  F1  hybrids  undergo  excessive B-cell 
activation and hypersecrete IgM; hypersecretion of IgM occurs in NZB fetal livers (3) 
and in NZB mice depleted of T  cells (46), all of which suggests an intrinsic defect or 
stimulation of these cells.  According to genetic studies of crosses between NZB and 
SWR  mice,  NZB  mice  may  have  a  subpopulation  of hyperactive  B  cells  whose 
number is determined by a  dominant gene(s) and whose Ig production is controlled 
by a  recessive gene(s)  (3).  Further experiments with crosses of NZB and the B cell- 
defective CBA/N mouse have shown  that  the NZB B-cell abnormality resulting in 
excessive Ig  production occurs almost  exclusively in  that  population  of NZB  cells 
affected by the CBA/N X-chromosome-linked defect (20,  47). However, a  role of T 
cells in the switch of B cells from IgM to IgG hypersecretion later in life has not yet 
been elucidated. How B-cell hyperactivity occurs in the other two autoimmune strains 
(MRL/1,  BXSB)  is  not  yet  clear,  but  in  MRL/1  mice  an  excessive T-helper cell 
component could be operative. Certainly the possibility that exogenous or endogenous 
polyclonal B-cell activators are responsible for initiating or enhancing B-cell activity 
should  also  be  considered  (4).  However,  our  results  strongly  suggest  that  B-cell 
hyperactivity is not caused by numerical or functional defects in nonspecific suppressor 
T  cells. 
Summary 
We have investigated in vitro the magnitude, nature, and regulation of spontaneous 
and mitogen-induced Ig secretion by splenic lymphocytes from several autoimmune 
murine strains (NZB, NZB ×  W, MRL/I, BXSB) and appropriate, normal mice. All 
autoimmune strains had increased numbers of mature splenic B lymphocytes, which 
secreted and/or contained Ig, compared to age-matched normal strains. In NZB and 
NZB  ×  W  mice, the high  frequency of mature  B  cells was  apparent  early in  life, 
whereas in MRL/1 and BXSB mice it was first noted shortly before the clinical onset 
of disease.  Spleen  cells  from  young autoimmune  mice  of all  four strains  secreted 
predominantly IgM, but with aging and the appearance of disease, the cells switched 
to  IgG  secretion  predominantly.  In  contrast,  spleen  cells  from  normal  mice  were 
predominantly IgM  secretors throughout the animals'  lives. Approximately  15% of 464  Ig SECRETION IN SYSTEMIC  LUPUS  ERYTHEMATOSUS  MICE 
the total Ig-secreting cells in older NZB, NZB X W, and MRL mice were committed 
to secretion of anti-ssDNA antibodies.  In both autoimmune and normal spleen cells, 
the B-cell population alone contained fewer secreting cells than the total lymphocyte 
population, indicating that T  cells were required to achieve maximal levels of plaque- 
forming cells. 
Spleen cells of NZB and NZB X W  mice had a greater response to lipopolysaccha- 
ride  (LPS)  than  other  autoimmune  and  normal  strains.  Responsiveness  to  LPS,  as 
measured by the frequency of induced Ig-secreting cells, was considerably diminished 
with  age  and  onset  of disease  in  all  autoimmune  but  not  in  normal  strains.  LPS- 
induced  Ig secretion  by  B  cells  of autoimmune  and  normal  mice  was  subject  to 
regulation  by  splenic  T  cells.  No  significant  differences  were  observed  between 
concanavalin-A  (Con A)  stimulated  spleen  cells from young and older autoimmune 
mice  and  normal  control  strains  in  effectively  suppressing  spontaneous  and  LPS- 
induced  Ig secretion.  Moreover,  B  cells  from  autoimmune  mice  and  from  normal 
strains were equally receptive to Con A-induced suppressor signals. T  cells from young 
and older NZB and BXSB mice added to a standard number of B cells from syngeneic 
young mice  provided  equal  help  in  enhancing  LPS-induced  Ig secretion,  and  this 
help in turn was equivalent to that provided by T  cells from normal mice of the same 
H-2  haplotype.  The  exception  was  the  MRL/1  strain;  T  cells  from  older  animals 
provided considerably  more  help  than  T  cells  from young MRL/I  or T  cells  from 
young and older H-2-eompatible normal mice. 
We would like to thank Mr. Mario Bourdon and Ms. Beverly Demmel for their skillful technical 
assistance.  The secretarial  and editorial  assistance of Ms.  Lorene Masewicz and Ms.  Phyllis 
Minick are greatefully acknowledged. We are grateful to Dr. D. H. Katz and Dr. S. Izui for 
critically reviewing the manuscript. 
Received  for publication 22 October 1979. 
References 
1.  Andrews,  B.  S.,  R.  A.  Eisenberg,  A.  N.  Theofilopoulos,  S.  Izui,  C.  B.  Wilson,  P.  J. 
McConahey, E. D. Murphy, J. B. Roths, and F.J. Dixon. 1978. Spontaneous murine lupus- 
like syndromes. Clinical and immunopathological manifestations in several  strains. J. Exp. 
Med. 148:1198. 
2.  Moutsopoulos, H. M., M. Boehm-Truitt, S. S. Kassan, and T. N. Chused.  1977. Demon- 
stration  of activation  of B  lymphocytes  in  New  Zealand  Black  mice  at  birth  by  an 
immunoradiometric. J. Immunol. 119:1639. 
3.  Manny, N., S, K. Datta, and R. S. Schwartz.  1979. Synthesis of IgM by cells of NZB and 
SWR mice and their crosses.J. Immunol. 122:1220. 
4.  Izui,  S.,  P.  J.  McConahey,  and  F.  J.  Dixon.  1978. Increased  spontaneous  polyclonal 
activation of B lymphocytes in  mice with  spontaneous autoimmune disease. J.  ImmunoL 
121:2213. 
5.  Krakauer,  R.  S., T. A. Waldmann,  and  W.  Strober.  1976. Loss of suppressor T  cells  in 
adult NZB/NZW mice..]. Exp. Med. 144:662. 
6.  Cantor,  H.,  L.  McVay-Boudreau, J.  Hugenberger,  K.  Naidorf,  F.  W.  Shen, and  R.  K. 
Gershon. 1978. Immunoregulatory circuits among T cell sets. II. Physiologic role of feedback 
inhibition in vivo: absence in NZB mice.J. Exp. Med. 147:1116. 
7.  Gershon, R. K., D. D. Fardley, K. Naidorf, and H. Cantor.  1978. Association of defective 
feedback suppressor T  cells activity with autoimmunity in NZB mice. Arthritis Rheum. 21 
(Suppl. 5):S 180. THEOFILOPOULOS,  SHAWLER, EISENBERG,  DIXON  465 
8.  Primi, D.,  L.  HammarstrSm,  and  C.  I.  E.  Smith.  1978. Genetic control of lymphocyte 
suppression. I. Lack of suppression in aged NZB mice is due to a B cell defect. J. Immunol. 
121:2241. 
9.  Murphy, E. D., and J. B. Roths.  1979. Autoimmunity and lymphproliferation: induction 
by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In 
Genetic Control of Autoimmune Disease. N.  R.  Rose, P.  E.  Bigazzi, and  N.  L. Warner, 
editors. Elsevier North-Holland, New York. 207. 
10.  Theofilopoulos, A. N., R. A. Eisenberg, M.  Bourdon, J.  S. Crowell, Jr., and F. J.  Dixon. 
1979.  Distribution of lymphocytes identified by surface markers in  murine strains with 
SLE-like syndromes.J. Exp. Med. 149:516. 
11.  Katz,  D.  H.,  and  D.  P.  Osborne, Jr.  1972. The  allogeneic effect  in  inbred  mice.  II. 
Establishment of the cellular interactions required for enhancement of antibody production 
by the graft-versus-host reaction.J. Exp. Med. 136:455. 
12.  Bonner,  W.  A., H.  R.  Hulett,  R.  G.  Sweet,  and  L.  A.  Herzenberg.  1972. Fluorescence 
activated cell sorter. Rev. Sci. Instrum. 43:404. 
13.  Molinaro, G. A., and S. Dray.  1974. Antibody-coated erythrocytes as manifold probe for 
antigens. Nature (Lond.).  248:515. 
14.  Kofler,  R.,  and  G.  Wick.  1977. Some  methodologic aspects of the  chromium  chloride 
method for coupling antigen to erythrocytes. J. Immunol. Methods. 16:201. 
15.  Bell, D.  A., C.  Clark,  S.  E.  Blomgren,  and J.  H.  Vaughan.  1973. Anti-DNA antibody 
production by lymphoid cells of NZB/W mice and human systemic lupus erythematosus 
(SLE). Clin. Immunol. Immunopathol. 1:293. 
16.  Roder, J. C., D. A. Bell, and S. K. Singhal. 1978. Loss of self-tolerance to single-stranded 
deoxyribonucleic acid (sDNA) in vitro.J. Immunol. 121:29. 
17.  Dutton, R. W.  1972. Inhibitory and stimulatory effects of concanavalin A on the response 
of mouse  spleen cell suspensions  to  antigens.  I.  Characterization  of the  inhibitory cell 
activity. J. Exp. Med. 136:1445. 
18.  Rich,  R.  R., and C. W. Pierce.  1973. Biological expressions of lymphocyte activation. I. 
Effects of phytomitogens on antibody synthesis in vitro. J. Exp. Med. 137:205. 
19.  Primi, D., L. Hammarstr6m, and C. I. E. Smith.  1979. Regulation of thymus-independent 
responses by Concanavalin A-activated spleen cells. Cell. Immunol. 42:90. 
20.  Taurog, J. D., H. M. Moutsopoulos, Y. J. Rosenberg, T. M. Chused, and A. D. Steinberg. 
1979. CBA in X-linked B cell defect prevents NZB B cell hyperactivity in F1 mice..]. Exp. 
Med. 150:31. 
21.  Cohen, P., M. Ziff, and E. S. Vitetta. 1978. Characterization ofa B cell defect in the NZB 
mouse manifested by an increased ratio of surface IgM to IgD.J. Immunol. 121:973. 
22.  Cohen, P. L., and M. Ziff. 1977. Abnormal polyclonal B cell activation in NZB/NZW FI 
mice..]. Immunol. 119:1534. 
23.  Bourgois, A., K. Kitajima, I. R. Hunter, and B. A. Askonas. 1977. Surface immunoglobulins 
of lipopolysaccharide-stimulated spleen cells. The behavior of IgM, IgD and IgG. Eur. J. 
Immunol. 7:151. 
24.  Kenny, J. J.,  s.  w.  Kessler, A. Ahmed,  R.  F.  Ashman,  and  I.  Sher.  1979. Changes  in 
surface immunoglobulin isotypes on purified antigen-binding cells after antigenic stimu- 
lation. J. Immunol. 122:2037. 
25.  Ebling, F., S. Freeman, and B. Hahn.  1979. Subpopulations of DNA anti-bodies in murine 
lupus. Arthritis Rheum. 22:606.  (Abstr.) 
26.  Papoian, R., R. Pillarisetty, and N. Talal. 1977. Immunological regulation of spontaneous 
antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW Fx 
mice. Immunologr. 32:75. 
27.  Sawada, S., and  N.  Talal.  1979. Characteristics of in  vitro production of antibodies to 
DNA in normal and autoimmune mice. J. Immunol. 122:2309. 
28.  Zan-Bar, I, S. Strober, and E. S. Vitetta.  1977. The relationship between surface immu- 466  Ig SECRETION  IN SYSTEMIC  LUPUS  ERYTHEMATOSUS  MICE 
noglobulin isotype and  immune function of murine B lymphocytes. I. Surface immuno- 
globulin isotypes of primed B cells in the spleen.J. Exp.  Med.  145:1188. 
29.  Zan-Bar, I., E. S. Vitetta, and S. Strober.  1977. The relationship between surface immu- 
noglobulin isotype and immune function of murine B lymphocytes. II. Surface immuno- 
globulin isotypes on unprimed B cells in the spleen.J. Exp.  Med.  145:1206. 
30.  McHugh,  Y.  E.,  and  B.  Bonavida.  1978. Autoreactive antibody-forming cells directed 
against thymocytes and thymus-derived lymphocytes.J. Immunol. 121:1090. 
31.  Strelkauskas, A. J., B. S. Wilson, R. T. Callery, L. Chess, and S. F. Schlossman.  1977. T- 
cell regulation of human peripheral blood B-cell responsiveness.,]. Exp.  Med.  146:1765. 
32.  Goodman,  M.  G.,  and  W.  O.  Weigle.  1979. T  cell  regulation  of  polyclonal  B  cell 
responsiveness. I. Helper effects ofT cells.J. Immunol. 192:2548. 
33.  Norcross, M.  A., and  R. T.  Smith.  1977. Regulation of B  cell proliferative responses to 
lipopolysaccharide by a subclass of thymus T  cells. J. Exp. Med.  145:1299. 
34.  Sawada, S., and N. Talal. 1979. Evidence for a helper cell promoting anti-DNA antibody 
production in murine lupus. Arthritis Rheum. 22:655.  (Abstr.) 
35.  Gershon, R. K.  1977. Suppressor T  cell dysfunction as a possible cause for autoimmunity. 
In Autoimmunity. N. Talal, editor. Academic Press, Inc., New York.  171. 
36.  Allison, A.  C.,  A.  M.  Denman,  and  R.  D.  Barnes.  1971. Cooperating and  controlling 
functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. II: 135. 
37.  Hardin, J. A., T. M. Chused, and A. D. Steinberg.  1973. Suppressor cells in the graft vs. 
host reaction. J. Immunol. 111:650. 
38.  Gershon, R. K., M. Horowitz, J. D. Kemp, D. B. Murphy, and E. D. Murphy.  1978. The 
cellular site of immunoregulatory breakdown in the lpr mutant mouse. In Genetic Control 
of Autoimmune Disease. N.  R.  Rose,  P.  E.  Bigazzi, and  N.  L. Warner, editors. Elsevier 
North-Holland, Inc., New York. 223. 
39.  Gershwin, M. E., J. j. Castles, R. M. Ikeda, K. Erickson, and J. Montero.  1979. Studies of 
congenitally immunologic mutant New Zealand mice. I. Autoimmune features of hereditary 
asplenic (Dh/+) NZB mice; reduction of naturally occurring thymocytotoxic antibody and 
normal suppressor formation.J. Immunol. 122:710. 
40.  Creighton, W. D., D. H. Katz, and F. J. Dixon. 1979. Antigen-specific immunocompetency, 
B  cell function  and  regulatory helper and  suppressor T  cell activities in  spontaneously 
autoimmune mice.J. Immunol. 193:2627. 
41.  Roder, J. C., A. D. Bell, and S. K. Singhal.  1977. Regulation of the immune response in 
autoimmune NZB/NZW F1 mice. I. The spontaneous generation of splenic suppressor cells. 
Cell. Immunol. 29:272. 
42.  Roder, J.  C.,  D.  A.  Bell, S.  K.  Singhal.  1978. Regulation of the  autoimmune  plaque- 
forming cell response to single-strand DNA (sDNA) in vitro. J. Immunol. 121:38. 
43.  Kysela, S., and A. D. Steinberg.  1973. Increased survival of NZB/W mice given multiple 
syngeneic young thymus grafts. Clin. Immunol. Immunopathol. 2:133. 
44.  Knight, J. C., and D. D. Adams.  1978. Failure of transferred thymus cells to suppress or 
prevent autoantibody production in NZB and NZB ×  NZW mice.J. Clin. Lab. Immunol. h 
151. 
45.  Hoffman,  A. A., and  R. J.  Harbeck.  1979. Immunoregulation in  New Zealand mice.  I. 
Failure of the transfer of syngeneic spleen or thymus cells to influence the natural disease 
in New Zealand mice. Arthritis Rheum. 22:412. 
46.  Chused, T.  M.,  H.  M.  Moutsopoulos, S. O.  Sharrow, C. T.  Hansen,  and  H.  C.  Morse. 
1978. Mechanism of autoimmune disease in New Zealand Black mice. In Genetic Control 
of Autoimmune Disease. N.  R.  Rose, P.  E.  Bigazzi, and  N.  L. Warner, editors. Elsevier 
North-Holland, Inc. 177. 
47.  Nakajima, P.  B.,  S.  K.  Datta,  R.  S.  Schwartz, and  B.  T.  Huber.  1979. Localization of 
spontaneously hyperactive B cells of NZB mice to specific B cell subset. Proc. Natl. Acad. Sci. 
U. S. A. 76:4613. 